Number of intraepithelial lymphocytes and presence of a subepithelial band in normal colonic mucosa differs according to stainings and evaluation method

Autor: Anne-Marie Kanstrup Fiehn, Peter Johan Heiberg Engel, Ulla Engel, Dea Natalie Munch Jepsen, Thomas Blixt, Julie Rasmussen, Signe Wildt, Wojciech Cebula, Andreea-Raluca Diac, Lars Kristian Munck

Publikováno v: Journal of Pathology Informatics, Vol 15, Iss , Pp 100374- (2024)

Chronic watery diarrhea is a frequent symptom. In approximately 10% of the patients, a diagnosis of microscopic colitis (MC) is established. The diagnosis relies on specific, but sometimes subtle, histopathological findings. As the histology of norma

Externí odkaz: https://doaj.org/article/8e783877457345e58927c84ae548a4fd

Low-dose azathioprine and allopurinol versus azathioprine monotherapy in patients with ulcerative colitis (AAUC): An investigator-initiated, open, multicenter, parallel-arm, randomised controlled trial

Autor: Marianne Kiszka-Kanowitz, Klaus Theede, Sandra Bohn Thomsen, Jacob Tveiten Bjerrum, Jørn Brynskov, Ida Benedikte Gottschalck, Elena Akimenko, Karen Lisa Hilsted, Anders Neumann, Signe Wildt, Lone Larsen, Jens Kristian Munk, Per Holger Ibsen, Huma Gul Rehana Janjua, Lise Lotte Gluud, Anette Mertz-Nielsen

Publikováno v: EClinicalMedicine, Vol 45, Iss , Pp 101332- (2022)

Summary: Background: Retrospective studies suggest that for patients with ulcerative colitis (UC) combination therapy with low-dose azathioprine and allopurinol (L-AZA/ALLO) may result in higher remission rates than monotherapy with azathioprine (AZA

Externí odkaz: https://doaj.org/article/97e99eefbcd243a1995ac82e77994a54

Autoimmune diseases in microscopic colitis: A Danish nationwide case–control study

Autor: Lars Kristian Munck, Matilde Winther-Jensen, Tine Jess, Nynne Nyboe Andersen, Signe Wildt

Publikováno v: Wildt, S, Munck, L K, Winther-Jensen, M, Jess, T & Nyboe Andersen, N 2021, ' Autoimmune diseases in microscopic colitis : A Danish nationwide case–control study ', Alimentary Pharmacology & Therapeutics, vol. 54, no. 11-12, pp. 1454-1462 . https://doi.org/10.1111/apt.16614

Background: The association between autoimmune diseases and microscopic colitis remains uncertain. Aims: To describe the association between autoimmune diseases and microscopic colitis by using a matched case–control design based on nationwide regi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7ad63d4f3121197803d8e6d8255f89b
https://doi.org/10.1111/apt.16614

Vedolizumab clearance in neonates, susceptibility to infections and developmental milestones:a prospective multicentre population-based cohort study

Autor: Lise Svenningsen, Petra Weimers, Ida Vind, Heidi G Sørensen, Bo Martin Bibby, Niels Uldbjerg, Signe Wildt, Jens Kjeldsen, Jens Kelsen, Simon Mark Dahl Baunwall, Thea Vestergaard, Jørn Brynskov, Christian Lodberg Hvas, Mette Mejlby Hansen, Daniel C. Baumgart, Kent V. Haderslev, Mette Julsgaard, Anne Grosen, Søren Lyhne, Lone Heimann Larsen

Publikováno v: Julsgaard, M, Baumgart, D C, Baunwall, S M D, Hansen, M M, Grosen, A, Bibby, B M, Uldbjerg, N, Kjeldsen, J, Sørensen, H G, Larsen, L, Wildt, S, Weimers, P, Haderslev, K V, Vind, I, Svenningsen, L, Brynskov, J, Lyhne, S, Vestergaard, T, Hvas, C L, Kelsen, J & NOVA Study Group 2021, ' Vedolizumab clearance in neonates, susceptibility to infections and developmental milestones : a prospective multicentre population-based cohort study ', Alimentary Pharmacology & Therapeutics, vol. 54, no. 10, pp. 1320-1329 . https://doi.org/10.1111/apt.16593
for the NOVA Study Group 2021, ' Vedolizumab clearance in neonates, susceptibility to infections and developmental milestones : a prospective multicentre population-based cohort study ', Alimentary Pharmacology and Therapeutics, vol. 54, no. 10, pp. 1320-1329 . https://doi.org/10.1111/apt.16593
Julsgaard, M, Baumgart, D C, Baunwall, S M D, Hansen, M M, Grosen, A, Bibby, B M, Uldbjerg, N, Kjeldsen, J, Sørensen, H G, Larsen, L, Wildt, S, Weimers, P, Haderslev, K V, Vind, I, Svenningsen, L, Brynskov, J, Lyhne, S, Vestergaard, T, Hvas, C L, Kelsen, J & for the NOVA Study Group 2021, ' Vedolizumab clearance in neonates, susceptibility to infections and developmental milestones : a prospective multicentre population-based cohort study ', Alimentary Pharmacology and Therapeutics, vol. 54, no. 10, pp. 1320-1329 . https://doi.org/10.1111/apt.16593
Julsgaard, M, Baumgart, D C, Baunwall, S M D, Hansen, M M, Grosen, A, Bibby, B M, Uldbjerg, N, Kjeldsen, J, Sørensen, H G, Larsen, L, Wildt, S, Weimers, P, Haderslev, K V, Vind, I, Svenningsen, L, Brynskov, J, Lyhne, S, Vestergaard, T, Hvas, C L, Kelsen, J & NOVA Study Group 2021, ' Vedolizumab clearance in neonates, susceptibility to infections and developmental milestones : a prospective multicentre population-based cohort study ', Alimentary Pharmacology and Therapeutics, vol. 54, no. 10, pp. 1320-1329 . https://doi.org/10.1111/apt.16593

BACKGROUND: Little is known about the consequences of intrauterine exposure to, and the post-natal clearance of, vedolizumab.AIMS: To investigate the levels of vedolizumab in umbilical cord blood of newborns and rates of clearance after birth, as wel

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fbc9b4f50165a611c861352ccf8f25b
https://vbn.aau.dk/ws/files/517706698/apt.16593.pdf

Author response for 'Effect of cholecystectomy on bile acid diarrhoea biomarkers: A prospective clinical study'

Autor: Jüri J. Rumessen, Signe Wildt, Christian Borup, Lars Kristian Munck, Pierre Bouchelouche, Nora Hedbäck, Dominique Rainteau, Emilie Gauliard

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::42370f60ff3b7017b15075c78640eeac
https://doi.org/10.1002/ygh2.489/v2/response1